vision loss with tirzepatide blindness and A small study published in JAMA Ophthalmology analyzed data from nine patients who developed severe issues, including Vision risks in patients – Popular weight-loss drugs linked to

Typically, candidates for tirzepatide for weight loss include: Adults with a body mass index (BMI) of 30 kg/m or greater (classified as obesity) Adults with a BMI of 27 kg/m or greater who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol Tirzepatide is not intended for individuals with a personal or family history of medullary thyroid carcinoma, those with multiple endocrine neoplasia syndrome type 2, or anyone with a known hypersensitivity to the medication

Tirzepatide follows a similar pattern, with indications spanning glycemic control and obesity treatment

For this study, one of the largest to date, Al-Aly and his colleagues analyzed data from the electronic records of more than 600,000 Veterans Affairs patients with diabetes over three years

Your prescriber will review your other medication when prescribing oral Semaglutide and advise you if any changes are needed Vision changes: seek medical attention if you get eye problems, such as changes in vision during treatment with oral Semaglutide A rare but serious side effect to be aware of is risk of pancreatitis